PRESS RELEASE published on 02/28/2025 at 07:30, 11 months 10 days ago Informations privilégiées / Autres communiqués ABIONYX s’engage dans la Déficience LCAT (Maladie de Norum) en soutenant les patients et préparant l'AMM, bénéficiant de la Désignation de Maladie Orpheline en Europe et aux USA ABIONYX EMA Déficience LCAT Maladie De Norum Désignation Orpheline
PRESS RELEASE published on 02/28/2025 at 07:30, 11 months 10 days ago Inside Information / Other news releases ABIONYX renews commitment to treat LCAT Deficiency (Norum's disease) and provides updates on advances, including submission of Marketing Authorization Application and Orphan Disease Designation ABIONYX LCAT Deficiency Rare Disease Day Marketing Authorization Application Orphan Disease Designation
BRIEF published on 02/27/2025 at 19:25, 11 months 10 days ago ABIONYX Pharma Reports Stable Revenue and Cash Position for 2024 2024 Financial Results Innovative Therapies ABIONYX Pharma Compassionate Access CRO Industry
BRIEF published on 02/27/2025 at 19:25, 11 months 10 days ago ABIONYX Pharma annonce un chiffre d'affaires et une situation de trésorerie stables pour 2024 Résultats Financiers 2024 ABIONYX Pharma Thérapies Innovantes Accès Compassionnel Industrie Des CRO
PRESS RELEASE published on 02/27/2025 at 19:20, 11 months 10 days ago Inside Information / Information on annual revenues ABIONYX Pharma reports €4.6m revenue and €3.2m cash at the end of Q4 2024. Details on business activities and financial performance included Revenue Cash Position Financial Update Biopharma ABIONYX Pharma
PRESS RELEASE published on 02/27/2025 at 19:20, 11 months 10 days ago Informations privilégiées / Information sur chiffre d’affaires annuel ABIONYX Pharma annonce un chiffre d'affaires consolidé de 4,6M€ et une trésorerie de 3,2M€ au 31 décembre 2024 Chiffre D'affaires Trésorerie Biopharma ABIONYX Pharma Thérapies Innovantes
BRIEF published on 02/20/2025 at 07:35, 11 months 18 days ago ABIONYX Pharma reçoit un soutien de 8,7 millions d'euros pour son projet sur le sepsis France 2030 ABIONYX Pharma Sepsis Soutien Financier Biomédicament
BRIEF published on 02/20/2025 at 07:35, 11 months 18 days ago ABIONYX Pharma receives €8.7 million in support for its sepsis project Financial Support France 2030 ABIONYX Pharma Sepsis Biomedicine
PRESS RELEASE published on 02/20/2025 at 07:30, 11 months 18 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma reçoit 8,7 M€ de soutien de l’Etat pour combattre le sepsis, 3ème cause de décès mondiale, grâce à son biomédicament CER-001 France 2030 ABIONYX Pharma Sepsis Soutien Financier Biomédicament
BRIEF published on 12/11/2024 at 12:16, 1 year 1 month ago Franchissement de seuil par la CDC dans ABIONYX PHARMA Droits De Vote Franchissement De Seuil CDC ABIONYX Pharma Bpifrance Participations
Published on 02/10/2026 at 09:01, 2 hours 58 minutes ago Star Copper to Deploy Advanced Deep-Penetrating 3D IP to Expedite 2026 Drill Program
Published on 02/10/2026 at 09:01, 2 hours 58 minutes ago Noram Fully Funded for 2026 and Engages GRE to Update PEA With Multiple High-Value Critical Mineral Byproduct Credits
Published on 02/10/2026 at 09:01, 2 hours 58 minutes ago Apex Mobilizes Second Drill Rig and Provides Phase I Update at the Rift Rare Earth Project in Nebraska, U.S.A.
Published on 02/10/2026 at 08:00, 3 hours 59 minutes ago Caledonia Mining Corporation Plc - Issue of Securities Pursuant to Long Term Incentive Plan Awards
Published on 02/10/2026 at 01:05, 10 hours 54 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 02/10/2026 at 11:35, 24 minutes ago Maldives Launches Tech4Nature Project to Safeguard Iconic Whale Sharks
Published on 02/10/2026 at 11:05, 54 minutes ago Partner Property Consultants Welcome Dervis Göksal as New Director in Hamburg, Germany
Published on 02/10/2026 at 11:05, 54 minutes ago Fruit Attraction 2026: the global meeting point shaping the future of the Fruit and Vegetable industry
Published on 02/09/2026 at 18:00, 17 hours 59 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 18 hours 14 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 18 hours 14 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 18 hours 14 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 18 hours 14 minutes ago Déclaration des droits de vote à fin janvier 2026
